A study to learn how BAY2927088 is taken up and handled by the body in healthy male participants

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-502771-38-00

Acronym

22249

Enrollment

Registered

2023-10-04

Start date

2024-01-24

Completion date

2024-05-08

Last updated

2023-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced non-small cell lung cancer with EGFR and/or HER2 mutations

None listed

Sex/Gender

Male

Age

18 Years to 64 Years

Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026